Gadobutrol Injection shortage
To Be Discontinued 4 presentations · 1 manufacturers · first FDA posting Jun 30, 2026 · last update Jun 30, 2026
Manufacturers: Jiangsu Hengrui Pharmaceuticals Co., Ltd.
Stated reasons (per FDA): Not stated
More info: FDA Drug Shortages Database · ASHP drug shortages list (search there for this drug)
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-02) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued | — | Discontinuance of single dose vials, the other two Imaging Bulk Package(IBP) strengths are to remain in supply: the IBP strengths (18.1416 g/30 mL and 39.3068 g/65 mL); Marketed by Fresenius Kabi, USA | Posted Jun 30, 2026 Updated Jun 30, 2026 Discontinued Jun 30, 2026 |
| Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-07) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued | — | Discontinuance of single dose vials, the other two Imaging Bulk Package(IBP) strengths are to remain in supply: the IBP strengths (18.1416 g/30 mL and 39.3068 g/65 mL); Marketed by Fresenius Kabi, USA | Posted Jun 30, 2026 Updated Jun 30, 2026 Discontinued Jun 30, 2026 |
| Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-10) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued | — | Discontinuance of single dose vials, the other two Imaging Bulk Package(IBP) strengths are to remain in supply: the IBP strengths (18.1416 g/30 mL and 39.3068 g/65 mL); Marketed by Fresenius Kabi, USA | Posted Jun 30, 2026 Updated Jun 30, 2026 Discontinued Jun 30, 2026 |
| Gadobutrol, Injection, 604.72 mg/mL (NDC 65219-281-15) | Jiangsu Hengrui Pharmaceuticals Co., Ltd. | To Be Discontinued | — | Discontinuance of single dose vials, the other two Imaging Bulk Package(IBP) strengths are to remain in supply: the IBP strengths (18.1416 g/30 mL and 39.3068 g/65 mL); Marketed by Fresenius Kabi, USA | Posted Jun 30, 2026 Updated Jun 30, 2026 Discontinued Jun 30, 2026 |